A photograph can cross a county faster than a dermatologist. DirectDerm built a practice around that simple advantage, then learned that some answers still need a room, a biopsy and a doctor nearby.
Its AI can release selected patients from an urgent cancer pathway without a dermatologist reviewing their images. The harder achievement is making that decision work inside a real health service.
Belle.ai (legally BelleTorus Corporation) is a Cambridge, Massachusetts company building AI that reads skin from an ordinary smartphone photo. Its Belle 1K Skin AI engine uses geometric image analysis to surface comparable references across more than 1,600 skin conditions and to produce objective severity scores for immune-mediated diseases like psoriasis, eczema, acne, vitiligo and alopecia. The goal is practical: give general practitioners, estheticians and providers in places with few dermatologists a tool to assess, document and track skin at the point of care. The technology is used across more than 60 countries and 1,000-plus provider sites, and the company has drawn contracts and recognition from ARPA-H and CMS.